Labcorp (LH) EVP gets 1,584-share award, 451 withheld for taxes

Rhea-AI Filing Summary

LABCORP HOLDINGS INC. executive EVP, Diagnostics Bryan T. Vaughn received 1,584 shares of common stock on March 26, 2026 as a performance award tied to results over the three-year period ended December 31, 2025. To cover tax obligations, 451 shares were withheld at $268.38 per share, leaving him with 6,745.5702 directly owned shares after these transactions.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Vaughn Bryan T

Role EVP, Diagnostics

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,584	$0.00	--
Tax Withholding	Common Stock	451	$268.38	$121K

Holdings After Transaction: Common Stock — 7,196.57 shares (Direct)

Footnotes (1)

1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025. Stock withholding to satisfy tax withholding obligations.

Key Figures

Performance award shares: 1,584 shares Tax withholding shares: 451 shares Tax withholding price: $268.38 per share +1 more

4 metrics

Performance award shares 1,584 shares Common stock grant on March 26, 2026

Tax withholding shares 451 shares Withheld to satisfy tax obligations at $268.38/share

Tax withholding price $268.38 per share Price used for 451-share tax withholding disposition

Post-transaction holdings 6,745.5702 shares Direct LABCORP common stock held after transactions

Key Terms

performance award, stock withholding, tax withholding obligations, Grant, award, or other acquisition

4 terms

performance award financial

"pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025"

stock withholding financial

"Stock withholding to satisfy tax withholding obligations."

tax withholding obligations financial

"Stock withholding to satisfy tax withholding obligations."

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vaughn Bryan T

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NORTH CAROLINA 27215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Diagnostics

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/26/2026		A(1)		1,584	A	$0	7,196.5702	D
Common Stock	03/26/2026		F(2)		451	D	$268.38	6,745.5702	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.

2. Stock withholding to satisfy tax withholding obligations.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Bryan T. Vaughn	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did LH executive Bryan T. Vaughn report?

Bryan T. Vaughn reported receiving 1,584 shares of LABCORP common stock as a performance-based award. On the same date, 451 shares were withheld to satisfy tax obligations, resulting in 6,745.5702 shares of direct ownership afterward.

Was the LABCORP (LH) insider transaction a market purchase or sale?

The filing shows a grant of 1,584 shares as compensation and a related tax withholding of 451 shares at $268.38. There was no open-market purchase or sale; these are routine compensation and tax-settlement entries.

How many LABCORP (LH) shares does Bryan T. Vaughn hold after this Form 4?

After the performance award grant and related tax withholding, Bryan T. Vaughn directly holds 6,745.5702 LABCORP common shares. This total reflects his updated post-transaction position as reported in the Form 4 filing.

What performance period was tied to Bryan T. Vaughn’s LABCORP share award?

The 1,584-share performance award granted to Bryan T. Vaughn on March 26, 2026 relates to company performance during a three-year period that ended on December 31, 2025, according to the filing’s footnote disclosure.

Why were 451 LABCORP (LH) shares disposed of in Bryan T. Vaughn’s Form 4?

The 451-share disposition is labeled as stock withholding to satisfy tax withholding obligations. This represents shares withheld by the company for taxes, not an open-market sale by the executive.